These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23179521)

  • 1. Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging.
    Di Martino M; De Filippis G; De Santis A; Geiger D; Del Monte M; Lombardo CV; Rossi M; Corradini SG; Mennini G; Catalano C
    Eur Radiol; 2013 Apr; 23(4):887-96. PubMed ID: 23179521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging.
    Haradome H; Grazioli L; Tinti R; Morone M; Motosugi U; Sano K; Ichikawa T; Kwee TC; Colagrande S
    J Magn Reson Imaging; 2011 Jul; 34(1):69-78. PubMed ID: 21598343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small (Golfieri R; Marini E; Bazzocchi A; Fusco F; Trevisani F; Sama C; Mazzella G; Cavuto S; Piscaglia F; Bolondi L
    Radiol Med; 2009 Dec; 114(8):1239-66. PubMed ID: 19697104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT.
    Marin D; Di Martino M; Guerrisi A; De Filippis G; Rossi M; Ginanni Corradini S; Masciangelo R; Catalano C; Passariello R
    Radiology; 2009 Apr; 251(1):85-95. PubMed ID: 19332848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis.
    Bartolozzi C; Donati F; Cioni D; Crocetti L; Lencioni R
    Eur Radiol; 2000; 10(11):1697-702. PubMed ID: 11097390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis.
    Di Martino M; Marin D; Guerrisi A; Baski M; Galati F; Rossi M; Brozzetti S; Masciangelo R; Passariello R; Catalano C
    Radiology; 2010 Sep; 256(3):806-16. PubMed ID: 20720069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of multidetector row computed tomography, superparamagnetic iron oxide-enhanced magnetic resonance imaging, and dual-contrast magnetic resonance imaging in predicting the appropriateness of a transplant recipient based on milan criteria: correlation with histopathological findings.
    Lee DH; Kim SH; Lee JM; Park HS; Lee JY; Yi NJ; Suh KS; Jang JJ; Han JK; Choi BI
    Invest Radiol; 2009 Jun; 44(6):311-21. PubMed ID: 19462486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Comparison of Multiple-Detector Computed Tomography and Dynamic Magnetic Resonance Imaging in the Diagnosis of Hepatocellular Carcinoma with Varying Degrees of Fibrosis.
    Lin MT; Wang CC; Cheng YF; Eng HL; Yen YH; Tsai MC; Tseng PL; Chang KC; Wu CK; Hu TH
    PLoS One; 2016; 11(11):e0166157. PubMed ID: 27829060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of imaging techniques in the diagnosis of hepatocellular carcinoma in patients who require a liver transplant.
    Villacastín Ruiz E; Caro-Patón Gómez A; Calero Aguilar H; Pérez Saborido B; García Pajares F; Sánchez Antolín G; Madrigal Rubiales B; Pacheco Sánchez D; Pintado Garrido R; Plaza Loma S; Escudero Caro T
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):412-20. PubMed ID: 26760587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma.
    Hanna RF; Miloushev VZ; Tang A; Finklestone LA; Brejt SZ; Sandhu RS; Santillan CS; Wolfson T; Gamst A; Sirlin CB
    Abdom Radiol (NY); 2016 Jan; 41(1):71-90. PubMed ID: 26830614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis.
    Golfieri R; Renzulli M; Lucidi V; Corcioni B; Trevisani F; Bolondi L
    Eur Radiol; 2011 Jun; 21(6):1233-42. PubMed ID: 21293864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic sensitivity of hepatocellular carcinoma imaging and its application to non-cirrhotic patients.
    Lin MT; Chen CL; Wang CC; Cheng YF; Eng HL; Wang JH; Chiu KW; Lee CM; Hu TH
    J Gastroenterol Hepatol; 2011 Apr; 26(4):745-50. PubMed ID: 21418303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT.
    Inoue T; Kudo M; Komuta M; Hayaishi S; Ueda T; Takita M; Kitai S; Hatanaka K; Yada N; Hagiwara S; Chung H; Sakurai T; Ueshima K; Sakamoto M; Maenishi O; Hyodo T; Okada M; Kumano S; Murakami T
    J Gastroenterol; 2012 Sep; 47(9):1036-47. PubMed ID: 22526270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rational imaging of hepatocellular carcinoma. The challenge of multimodal diagnostic criteria].
    Kircher A; Bongartz G; Merkle EM; Zech CJ
    Radiologe; 2014 Jul; 54(7):664-72. PubMed ID: 25047522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Small hepatocellular carcinoma in patients with hepatitis B-induced cirrhosis: a comparison between MRI and MDCT].
    Jiang YY; Wang XY; Guo XM; Jiang XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Dec; 42(6):767-72. PubMed ID: 21170112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT.
    Onishi H; Kim T; Imai Y; Hori M; Nagano H; Nakaya Y; Tsuboyama T; Nakamoto A; Tatsumi M; Kumano S; Okada M; Takamura M; Wakasa K; Tomiyama N; Murakami T
    Eur Radiol; 2012 Apr; 22(4):845-54. PubMed ID: 22057248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.
    Semaan S; Vietti Violi N; Lewis S; Chatterji M; Song C; Besa C; Babb JS; Fiel MI; Schwartz M; Thung S; Sirlin CB; Taouli B
    Eur Radiol; 2020 Feb; 30(2):1020-1030. PubMed ID: 31673837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.